Purdue University innovators have developed highly potent and selective compounds for use in the treatment of tuberculosis, which is one of the top 10 causes of death worldwide.
Apr 8, 2021
0
7
(HealthDay)—In 2020, there was a large decrease in tuberculosis (TB) cases, according to research published in the March 26 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Mar 31, 2021
0
3
The median health care delay for patients with tuberculosis (TB) in the United States is 24 days, according to a study published online March 23 in The Lancet Infectious Diseases.
Mar 26, 2021
0
5
As the UK marks one year since the country went into lockdown, we've also been looking further afield to countries disproportionately burdened by infectious diseases, including COVID-19. To mark this year's World TB Day, ...
Mar 25, 2021
0
8
Tuberculosis remains a rare disease in the United States, but when it does occur, delays in diagnosing it often exceed recommendations by the World Health Organization, according to a new report by Harvard Medical School ...
Mar 22, 2021
0
14
Although tuberculosis, or TB, killed nearly as many people as COVID-19 (approx. 1.8 million) in 2020, it did not receive as much media and public attention. The pandemic has proven that transmissible infection is indeed a ...
Mar 19, 2021
0
6
South Africa's long-awaited tuberculosis (TB) prevalence survey results were recently released. This is the first national prevalence survey of its kind for TB in South Africa.
Mar 15, 2021
0
4
Almost all patients who received a new treatment for highly drug-resistant tuberculosis are still clear of the disease two years after a medical trial in South Africa, findings from a long-term study showed Thursday.
Mar 11, 2021
0
4
Antiretroviral treatment (ART) reduces the risk of developing active tuberculosis (TB) in people also infected with HIV-1, by dampening the activation of the body's immune response. These findings could help improve treatment ...
Mar 5, 2021
0
10
Research has found fidaxomicin, an antibiotic usually used to treat bowel infections, prevents growth of resistant strains of Mycobacterium tuberculosis (MTb) in the lab.
Feb 17, 2021
0
3
